ArticleInternational journal of ophthalmology2017

Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model.

Mao-Song Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.